Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 14 studies | 27% ± 15% | |
fibroblast | 8 studies | 23% ± 4% | |
type II pneumocyte | 5 studies | 21% ± 4% | |
GABAergic neuron | 5 studies | 36% ± 15% | |
pericyte | 5 studies | 27% ± 13% | |
capillary endothelial cell | 4 studies | 20% ± 6% | |
glutamatergic neuron | 4 studies | 32% ± 12% | |
interneuron | 4 studies | 35% ± 13% | |
renal principal cell | 4 studies | 28% ± 5% | |
epithelial cell | 3 studies | 21% ± 4% | |
basal cell | 3 studies | 30% ± 13% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 37% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 4990.87 | 578 / 578 | 98% | 44.18 | 1129 / 1155 |
esophagus | 99% | 4719.92 | 1426 / 1445 | 96% | 35.46 | 175 / 183 |
breast | 98% | 2313.76 | 451 / 459 | 92% | 49.08 | 1024 / 1118 |
kidney | 100% | 3194.42 | 89 / 89 | 86% | 35.86 | 774 / 901 |
stomach | 100% | 3178.02 | 359 / 359 | 85% | 23.13 | 243 / 286 |
intestine | 99% | 4286.64 | 958 / 966 | 83% | 17.56 | 440 / 527 |
prostate | 99% | 2073.89 | 242 / 245 | 78% | 11.82 | 391 / 502 |
uterus | 99% | 2428.43 | 168 / 170 | 77% | 17.77 | 352 / 459 |
bladder | 100% | 3824.48 | 21 / 21 | 61% | 14.90 | 308 / 504 |
brain | 52% | 614.11 | 1385 / 2642 | 88% | 17.57 | 623 / 705 |
thymus | 95% | 1367.15 | 620 / 653 | 43% | 6.76 | 261 / 605 |
pancreas | 43% | 400.46 | 141 / 328 | 89% | 21.55 | 158 / 178 |
skin | 88% | 3410.84 | 1585 / 1809 | 19% | 2.33 | 91 / 472 |
adipose | 99% | 2388.11 | 1188 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 32.37 | 42 / 45 |
blood vessel | 83% | 1089.82 | 1107 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 50% | 418.65 | 130 / 258 | 32% | 4.76 | 74 / 230 |
ovary | 61% | 624.19 | 110 / 180 | 13% | 1.39 | 56 / 430 |
heart | 63% | 619.60 | 541 / 861 | 0% | 0 | 0 / 0 |
muscle | 30% | 231.59 | 242 / 803 | 0% | 0 | 0 / 0 |
liver | 1% | 9.12 | 3 / 226 | 18% | 2.31 | 75 / 406 |
spleen | 9% | 61.64 | 21 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.28 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097324 | Biological process | melanocyte migration |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0033026 | Biological process | negative regulation of mast cell apoptotic process |
GO_0045636 | Biological process | positive regulation of melanocyte differentiation |
GO_0001755 | Biological process | neural crest cell migration |
GO_0097531 | Biological process | mast cell migration |
GO_0042098 | Biological process | T cell proliferation |
GO_1902035 | Biological process | positive regulation of hematopoietic stem cell proliferation |
GO_0001541 | Biological process | ovarian follicle development |
GO_0033024 | Biological process | mast cell apoptotic process |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0007155 | Biological process | cell adhesion |
GO_0002763 | Biological process | positive regulation of myeloid leukocyte differentiation |
GO_1901534 | Biological process | positive regulation of hematopoietic progenitor cell differentiation |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_0002573 | Biological process | myeloid leukocyte differentiation |
GO_0070662 | Biological process | mast cell proliferation |
GO_0002687 | Biological process | positive regulation of leukocyte migration |
GO_0046579 | Biological process | positive regulation of Ras protein signal transduction |
GO_0008584 | Biological process | male gonad development |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0035234 | Biological process | ectopic germ cell programmed cell death |
GO_0070668 | Biological process | positive regulation of mast cell proliferation |
GO_0035162 | Biological process | embryonic hemopoiesis |
GO_0005615 | Cellular component | extracellular space |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0030175 | Cellular component | filopodium |
GO_0005737 | Cellular component | cytoplasm |
GO_0030027 | Cellular component | lamellipodium |
GO_0008083 | Molecular function | growth factor activity |
GO_0005173 | Molecular function | stem cell factor receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | KITLG |
Protein name | Kit ligand (Mast cell growth factor) (MGF) (Stem cell factor) (SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand (sKITLG)] KIT ligand |
Synonyms | SCF MGF |
Description | FUNCTION: Ligand for the receptor-type protein-tyrosine kinase KIT. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. KITLG/SCF and KIT also transmit signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. KITLG/SCF and KIT promote activation of STAT family members STAT1, STAT3 and STAT5. KITLG/SCF and KIT promote activation of PLCG1, leading to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KITLG/SCF acts synergistically with other cytokines, probably interleukins. |
Accessions | P21583 ENST00000347404.10 [P21583-2] ENST00000646633.1 S4R384 A0A2R8Y515 ENST00000357116.4 ENST00000552044.1 S4R442 ENST00000644744.1 [P21583-1] |